Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
0.9556
-0.1144 (-10.69%)
At close: May 15, 2026, 4:00 PM EDT
0.9283
-0.0273 (-2.86%)
After-hours: May 15, 2026, 7:58 PM EDT
Arcadia Biosciences Revenue
Arcadia Biosciences had revenue of $1.10M in the quarter ending March 31, 2026, a decrease of -8.33%. This brings the company's revenue in the last twelve months to $4.76M, down -9.53% year-over-year. In the year 2025, Arcadia Biosciences had annual revenue of $4.86M, down -3.71%.
Revenue (ttm)
$4.76M
Revenue Growth
-9.53%
P/S Ratio
0.41
Revenue / Employee
$594,750
Employees
8
Market Cap
1.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.86M | -187.00K | -3.71% |
| Dec 31, 2024 | 5.05M | 591.00K | 13.27% |
| Dec 31, 2023 | 4.45M | -2.96M | -39.96% |
| Dec 31, 2022 | 7.42M | 638.00K | 9.41% |
| Dec 31, 2021 | 6.78M | -1.25M | -15.61% |
| Dec 31, 2020 | 8.03M | 6.87M | 587.25% |
| Dec 31, 2019 | 1.17M | -295.00K | -20.15% |
| Dec 31, 2018 | 1.46M | -2.56M | -63.64% |
| Dec 31, 2017 | 4.03M | 838.00K | 26.29% |
| Dec 31, 2016 | 3.19M | -2.23M | -41.12% |
| Dec 31, 2015 | 5.41M | -1.57M | -22.46% |
| Dec 31, 2014 | 6.98M | 504.00K | 7.78% |
| Dec 31, 2013 | 6.48M | -532.00K | -7.59% |
| Dec 31, 2012 | 7.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wing Yip Food Holdings Group | 135.19M |
| Natural Alternatives International | 135.16M |
| Coffee Holding Co. | 100.54M |
| Farmmi | 27.97M |
| Australian Oilseeds Holdings | 27.34M |
| Paranovus Entertainment Technology | 12.42M |
| Oriental Rise Holdings | 12.22M |
| Nocera | 8.77M |
RKDA News
- 3 days ago - Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 7 weeks ago - Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights - GlobeNewsWire
- 3 months ago - Arcadia Biosciences files to sell 1.67M shares of common stock for holders - TheFly
- 4 months ago - Arcadia announces exercise of preferred investment options for $2.1M in proceeds - TheFly
- 4 months ago - Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources - GlobeNewsWire
- 6 months ago - Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 9 months ago - Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights - GlobeNewsWire